| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000035841 |
| Receipt No. | R000040795 |
| Scientific Title | Comparison of analgesic efficacy of lateral femoral cutaneous nerve block and local infiltration anesthesia after total hip arthroplasty |
| Date of disclosure of the study information | 2019/04/01 |
| Last modified on | 2020/09/28 (Ver. 6) |
| Basic information | ||
| Public title | Comparison of analgesic efficacy of lateral femoral cutaneous nerve block and local infiltration anesthesia after total hip arthroplasty | |
| Acronym | Comparison of analgesic efficacy of lateral femoral cutaneous nerve block and local infiltration anesthesia after total hip arthroplasty | |
| Scientific Title | Comparison of analgesic efficacy of lateral femoral cutaneous nerve block and local infiltration anesthesia after total hip arthroplasty | |
| Scientific Title:Acronym | Comparison of analgesic efficacy of lateral femoral cutaneous nerve block and local infiltration anesthesia after total hip arthroplasty | |
| Region |
|
|
| Condition | ||
| Condition | The patients who undergo total hip arthroplasty | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | It aims to compare postoperative analgesic effect of lateral femoral cutaneous nerve block and local infiltration anesthesia in total hip arthroplasty |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Numerical rating scale of end of surgery and 1,3,6,12,18 and 24 hours after surgery |
| Key secondary outcomes | Nausea and vomiting 24 hours after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | All patients were anesthetized under total intravenous anesthesia with propofol and remifentanil. After induction of anesthesia, patients received a femoral nerve block using 20ml of 0.25% levobupivacaine and a lateral femoral cutaneous nerve block using 20ml of 0.25% levobupivacaine. All patients received bolus administration of 0.25mg fentanyl 30 min before the end of surgery and 0.25mg fentanyl at skin closure. They received 1000mg acetaminophen intravenously at end of surgery, and 6, 12, 18 and 24 hours postoperatively. Postoperative pain was evaluated by nursing staffs using a numerical rating scale (NRS) at 0, 1, 3, 6, 12, 18 and 24 hours postoperatively. Frequency of use of rescue analgesics and consumption of rescue analgesics were recorded for 12 and 24 hours after surgery. | |
| Interventions/Control_2 | All patients were anesthetized under total intravenous anesthesia with propofol and remifentanil. After induction of anesthesia, patients received a femoral nerve block using 20ml of 0.25% levobupivacaine. All patients received bolus administration of 0.25mg fentanyl 30 min before the end of surgery and 0.25mg fentanyl at skin closure. At the time of skin closure the surgeon injected 20 ml of 0.25% levobupivacaine around the skin incision.They received 1000mg acetaminophen intravenously at end of surgery, and 6, 12, 18 and 24 hours postoperatively. Postoperative pain was evaluated by nursing staffs using a numerical rating scale (NRS) at 0, 1, 3, 6, 12, 18 and 24 hours postoperatively. Frequency of use of rescue analgesics and consumption of rescue analgesics were recorded for 12 and 24 hours after surgery. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patients weighing 50-70 kg and undergoing elective total hip arthroplasty | |||
| Key exclusion criteria | 1. ASA physical status 3-6
2. Liver dysfunction 3. Allergy to acetaminophen or local anesthetics |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagasaki Rosai Hospital | ||||||
| Division name | Department of anesthesia | ||||||
| Zip code | 8570016 | ||||||
| Address | 2-12-5, Setogoe, Sasebo, Nagasaki, Japan | ||||||
| TEL | 0956-49-2191 | ||||||
| neko-maru178@hotmail.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagasaki Rosai Hospital | ||||||
| Division name | Department of anesthesia | ||||||
| Zip code | 8570016 | ||||||
| Address | 2-12-5, Setogoe, Sasebo, Nagasaki, Japan | ||||||
| TEL | 0956-49-2191 | ||||||
| Homepage URL | |||||||
| neko-maru178@hotmail.co.jp | |||||||
| Sponsor | |
| Institute | Nagasaki Rosai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nagasaki Rosai Hospital |
| Address | 2-12-5, Setogoe, Sasebo, Nagasaki, Japan |
| Tel | 0956-49-2191 |
| shomu@nagasakih.johas.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 長崎労災病院(長崎県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 50 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040795 |